Clinical Trials Directory

Trials / Sponsors / Lung Biotechnology PBC

Lung Biotechnology PBC

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Phase 32018-12-10
CompletedBeraprost-314d Added-on to Tyvaso® (BEAT)
Pulmonary Arterial Hypertension
Phase 32013-05-31
WithdrawnA Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonar
Pulmonary Arterial Hypertension
Phase 32011-11-01
CompletedDose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With
Pulmonary Arterial Hypertension
Phase 22010-02-01
CompletedExtension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Pulmonary Arterial Hypertension
Phase 22009-11-30
CompletedAn Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients
Pulmonary Arterial Hypertension
Phase 22009-02-28
CompletedA Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Berapro
Pulmonary Arterial Hypertension
Phase 22009-01-31
TerminatedEffects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic
Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
Phase 22008-06-01